Observational studyMediators of inflammation2013

Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study.

Boel Mörck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.